Trademark: 90505371
Word
TOPELIA THERAPEUTICS
Status Date
Tuesday, May 7, 2024
Filing Date
Tuesday, February 2, 2021
Published for Opposition
Tuesday, April 5, 2022
5 pharmaceutical preparations for the treatment of COVID 19, Corona viruses, Influenza, Autism, Alzheimer's, Parkinson's Disease, Multiple Sclerosis, and Epstein-Barr Virus
Feb 5, 2021
New Application Entered
May 6, 2021
New Application Office Supplied Data Entered
Sep 2, 2021
Non-Final Action Written
Aug 30, 2021
Assigned To Examiner
Sep 2, 2021
Non-Final Action E-Mailed
Sep 2, 2021
Notification Of Non-Final Action E-Mailed
Feb 23, 2022
Teas Response To Office Action Received
Feb 23, 2022
Correspondence Received In Law Office
Feb 24, 2022
Teas/Email Correspondence Entered
Feb 25, 2022
Approved For Pub - Principal Register
Feb 28, 2022
Assigned To Lie
Apr 5, 2022
Published For Opposition
Mar 16, 2022
Notification Of Notice Of Publication E-Mailed
Apr 5, 2022
Official Gazette Publication Confirmation E-Mailed
May 31, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 16, 2022
Assigned To Examiner
Dec 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2022
Sou Teas Extension Received
Nov 30, 2022
Sou Extension 1 Filed
Nov 30, 2022
Sou Extension 1 Granted
May 16, 2023
Teas Statement Of Use Received
May 16, 2023
Use Amendment Filed
Jun 14, 2023
Statement Of Use Processing Complete
Jun 7, 2023
Case Assigned To Intent To Use Paralegal
Jun 17, 2023
Non-Final Action E-Mailed
Jun 17, 2023
Su - Non-Final Action - Written
Jun 17, 2023
Notification Of Non-Final Action E-Mailed
May 6, 2024
Assigned To Lie
May 6, 2024
Correspondence Received In Law Office
May 6, 2024
Teas/Email Correspondence Entered
May 7, 2024
Allowed Principal Register - Sou Accepted
May 7, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 8, 2023
Application Extension Granted/Receipt Provided
Sep 8, 2023
Application Extension To Response Period - Received
Dec 15, 2023
Teas Response To Office Action Received
Trademark Alertz updated from USPTO on 2030-01-24
